SG11201506047PA - Prophylactic or therapeutic drug for constipation - Google Patents
Prophylactic or therapeutic drug for constipationInfo
- Publication number
- SG11201506047PA SG11201506047PA SG11201506047PA SG11201506047PA SG11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA SG 11201506047P A SG11201506047P A SG 11201506047PA
- Authority
- SG
- Singapore
- Prior art keywords
- constipation
- prophylactic
- therapeutic drug
- therapeutic
- drug
- Prior art date
Links
- 206010010774 Constipation Diseases 0.000 title 1
- 229940043274 prophylactic drug Drugs 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 229940126585 therapeutic drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013019754 | 2013-02-04 | ||
PCT/JP2014/052465 WO2014119787A1 (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201506047PA true SG11201506047PA (en) | 2015-09-29 |
Family
ID=51262485
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506047PA SG11201506047PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
SG10201700267PA SG10201700267PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201700267PA SG10201700267PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
Country Status (18)
Country | Link |
---|---|
US (1) | US10022389B2 (en) |
EP (1) | EP2952206B1 (en) |
JP (1) | JP5807767B2 (en) |
KR (1) | KR102078433B1 (en) |
CN (1) | CN104955481B (en) |
AU (1) | AU2014213251B2 (en) |
BR (1) | BR112015017541A2 (en) |
CA (1) | CA2899834C (en) |
ES (1) | ES2694110T3 (en) |
HK (1) | HK1211479A1 (en) |
IL (1) | IL240192A (en) |
MX (1) | MX346453B (en) |
MY (1) | MY176162A (en) |
PH (1) | PH12015501696A1 (en) |
RU (1) | RU2648467C2 (en) |
SG (2) | SG11201506047PA (en) |
TW (1) | TWI659739B (en) |
WO (1) | WO2014119787A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019142774A (en) * | 2016-06-20 | 2019-08-29 | 大正製薬株式会社 | Intestinal environment-improving agent |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2830424C3 (en) * | 1978-07-11 | 1982-04-15 | Bayer Ag, 5090 Leverkusen | alpha-glucosidase inhibitors |
US5651988A (en) | 1995-08-18 | 1997-07-29 | Xyrofin Oy | Combination osmotic and bulk forming laxatives |
DE60332743D1 (en) | 2002-08-08 | 2010-07-08 | Kissei Pharmaceutical | PYRAZOL DERIVATIVE, MEDICAL COMPOSITION, MEDICAL USE THEREOF, AND INTERMEDIATE PRODUCT FOR THE PRODUCTION THEREOF |
JP2004137245A (en) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | Pyrazole derivative, pharmaceutical composition containing the same, its pharmaceutical use and production intermediate |
JP4606876B2 (en) | 2002-08-27 | 2011-01-05 | キッセイ薬品工業株式会社 | Pyrazole derivative, pharmaceutical composition containing the same, and pharmaceutical use thereof |
CN1744916A (en) | 2002-12-04 | 2006-03-08 | 橘生药品工业株式会社 | Preventive or remedy for diseases caused by hyperglycemia |
DE102004028241B4 (en) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | New fluoroglycoside derivatives of pyrazoles, medicines containing these compounds and manufacture of these medicines |
TWI387454B (en) * | 2004-09-02 | 2013-03-01 | Sucampo Ag | Method and composition for treating gastrointestinal disorder |
AU2007252432B2 (en) | 2006-05-19 | 2011-11-17 | Taisho Pharmaceutical Co., Ltd. | C-phenyl glycitol compound |
MX2008016231A (en) | 2006-06-29 | 2009-01-16 | Taisho Pharma Co Ltd | C-phenyl 1-thioglucitol compound. |
TW200817424A (en) | 2006-08-04 | 2008-04-16 | Daiichi Sankyo Co Ltd | Benzylphenyl glucopyranoside derivatives |
TWI499414B (en) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | Inhibitors of sodium glucose co-transporter 2 and methods of their use |
WO2008072726A1 (en) | 2006-12-14 | 2008-06-19 | Taisho Pharmaceutical Co., Ltd. | 1-phenyl 1-thio-d-glucitol derivative |
GB2447067A (en) * | 2007-02-20 | 2008-09-03 | Branko R Babic | Alteration of osmotic gradients by polyhydroxy compounds |
CN101910189B (en) | 2007-12-27 | 2013-06-19 | 橘生药品工业株式会社 | Monosebacate of pyrazole derivative |
ES2385185T3 (en) | 2008-04-16 | 2012-07-19 | Kissei Pharmaceutical Co., Ltd. | Hemifumarate of a pyrazole derivative |
US8466113B2 (en) * | 2009-02-23 | 2013-06-18 | Taisho Pharmaceutical Co., Ltd. | 4-isopropylphenyl glucitol compounds as SGLT1 inhibitors |
JP2013224263A (en) | 2010-08-19 | 2013-10-31 | Taisho Pharmaceutical Co Ltd | 4-isopropylphenyl glucitol compound |
RU2013112368A (en) | 2010-08-20 | 2014-09-27 | Тайсо Фармасьютикал Ко., Лтд. | CRYSTAL FORM OF 4-ISOPROPHYLPHENYL GLUCITOL COMPOUND AND METHOD FOR PRODUCING IT |
EP2607360B1 (en) | 2010-08-20 | 2015-08-19 | Taisho Pharmaceutical Co., Ltd. | 4-Isopropyl-6-methoxyphenyl glucitol compound |
AR087701A1 (en) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | PIRAZOL DERIVATIVES WITH SGLT1 INHIBITING ACTIVITY |
US9273085B2 (en) | 2012-05-07 | 2016-03-01 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative and use thereof for medical purposes |
DK3489226T3 (en) * | 2012-11-20 | 2021-04-26 | Lexicon Pharmaceuticals Inc | Inhibitors of sodium glucose cotransport 1 |
-
2014
- 2014-02-03 RU RU2015137671A patent/RU2648467C2/en active
- 2014-02-03 CA CA2899834A patent/CA2899834C/en active Active
- 2014-02-03 MY MYPI2015702526A patent/MY176162A/en unknown
- 2014-02-03 MX MX2015010029A patent/MX346453B/en active IP Right Grant
- 2014-02-03 EP EP14746685.8A patent/EP2952206B1/en active Active
- 2014-02-03 ES ES14746685.8T patent/ES2694110T3/en active Active
- 2014-02-03 AU AU2014213251A patent/AU2014213251B2/en not_active Ceased
- 2014-02-03 BR BR112015017541A patent/BR112015017541A2/en not_active Application Discontinuation
- 2014-02-03 US US14/765,134 patent/US10022389B2/en active Active
- 2014-02-03 SG SG11201506047PA patent/SG11201506047PA/en unknown
- 2014-02-03 KR KR1020157018999A patent/KR102078433B1/en active IP Right Grant
- 2014-02-03 JP JP2014526017A patent/JP5807767B2/en not_active Expired - Fee Related
- 2014-02-03 WO PCT/JP2014/052465 patent/WO2014119787A1/en active Application Filing
- 2014-02-03 CN CN201480007190.8A patent/CN104955481B/en not_active Expired - Fee Related
- 2014-02-03 SG SG10201700267PA patent/SG10201700267PA/en unknown
- 2014-02-05 TW TW103103751A patent/TWI659739B/en not_active IP Right Cessation
-
2015
- 2015-07-28 IL IL240192A patent/IL240192A/en active IP Right Grant
- 2015-07-31 PH PH12015501696A patent/PH12015501696A1/en unknown
- 2015-12-15 HK HK15112295.0A patent/HK1211479A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2648467C2 (en) | 2018-03-26 |
PH12015501696B1 (en) | 2015-10-12 |
CA2899834A1 (en) | 2014-08-07 |
EP2952206A4 (en) | 2016-06-15 |
MX346453B (en) | 2017-03-17 |
US10022389B2 (en) | 2018-07-17 |
MX2015010029A (en) | 2015-10-30 |
CN104955481B (en) | 2017-10-24 |
TW201517903A (en) | 2015-05-16 |
EP2952206A1 (en) | 2015-12-09 |
AU2014213251B2 (en) | 2017-07-20 |
PH12015501696A1 (en) | 2015-10-12 |
JP5807767B2 (en) | 2015-11-10 |
US20150374735A1 (en) | 2015-12-31 |
CN104955481A (en) | 2015-09-30 |
IL240192A (en) | 2017-03-30 |
KR20150112949A (en) | 2015-10-07 |
AU2014213251A1 (en) | 2015-08-27 |
JPWO2014119787A1 (en) | 2017-01-26 |
HK1211479A1 (en) | 2016-05-27 |
EP2952206B1 (en) | 2018-10-24 |
RU2015137671A (en) | 2017-03-10 |
MY176162A (en) | 2020-07-24 |
CA2899834C (en) | 2020-09-01 |
BR112015017541A2 (en) | 2017-07-11 |
ES2694110T3 (en) | 2018-12-18 |
KR102078433B1 (en) | 2020-02-17 |
TWI659739B (en) | 2019-05-21 |
IL240192A0 (en) | 2015-09-24 |
SG10201700267PA (en) | 2017-02-27 |
WO2014119787A1 (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180684T1 (en) | Drug combination | |
ZA201507576B (en) | Pharmaceutical combination drug | |
GB201308440D0 (en) | Therapeutic | |
HK1223833A1 (en) | Pharmaceutical dosage forms | |
ZA201600027B (en) | Pharmaceutical preparation | |
EP3046556A4 (en) | Combination drug therapy | |
EP2968179A4 (en) | Controlled release pharmaceutical dosage forms | |
GB201318668D0 (en) | Sonosensitive therapeutic | |
HK1220633A1 (en) | Pharmaceutical preparation comprising aminopyrazole derivative | |
HK1211479A1 (en) | Prophylactic or therapeutic drug for constipation | |
ZA201506465B (en) | Pharmaceutical preparation | |
GB201320786D0 (en) | Medicament | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201305073D0 (en) | Therapeutic means |